Novavax
stock was climbing Tuesday after the company announced that an initial one million doses of its Covid-19 vaccine are now available for use in the U.K.
Shares of
Novavax
(ticker: NVAX) have struggled this year, tumbling 86% so far in 2022, and 90% in the past 12 months. The company slashed its full-year revenue guidance back in August, and posted a disappointing second quarter amid poor demand for its Covid-19 vaccine.
Zydus Wellness in Q2 noticed broad-based development. The corporate, which just lately acquired Naturelle India, stated it continues to stay...
Gautam Adani, Sagar Adani, and senior govt Vneet Jaain haven't been charged with violating the US Overseas Corrupt Practices Act...
Shares of Tremendous Micro Laptop slipped once more Tuesday ending a rally that appeared to sign a restoration from latest...
Morgan Stanley purchased over 6.7 lakh shares in Niyogin Fintech at a complete price of Rs 3.74 crore through a...
LONDON - Xtrackers, an funding firm with variable capital based mostly in Luxembourg, has introduced adjustments to the reference index...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
